CHENNAI, TAMIL NADU, INDIA 22-01-2013 06:46 PM
TAKE Solutions Ltd has announced its first implementation of Mobile-based Patient Diary System (PaDiSys) for a biopharmaceutical company focused on the development of small molecule drugs for major unmet medical needs that treat male and female reproductive disorders. TAKE is the exclusive reseller worldwide of PaDiSys through a strategic partnership with NowPos, a company that specializes in developing mobile-based solutions for Life Sciences.
The PaDiSys (Patient Diary System) solution helps sponsors to improve patients' treatment adherence and compliance towards the protocal and patient reported outcomes. PaDiSys allows sponsors to walk away from a paper based approach to filling out questionnaires and assessments during clinical trials, thereby enabling the clinical staff to closely monitor patient compliance and safety. Clinicians and Site staff are equipped with easy-to-use analytical dashboards that monitor patient data in real time, and can intervene when necessary to ensure compliance. With quick deployment, implementation and simple use for both subjects and clinicians, there is a much higher adherence to a study regiment, thus improving trial compliance.
The Take Solutions Ltd stock was trading at Rs.26.80, down by Rs.0.50 or 1.83%. The stock hit an intraday high of Rs.27.90 and low of Rs.26.50.
The total traded quantity was 6716 compared to 2 week average of 16741.
